A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole

Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...

Full description

Bibliographic Details

Published in:	Journal of Community Hospital Internal Medicine Perspectives
Main Authors:	Mohsin Hamid, Bilal Lashari, Irfan Ahsan, Ida Micaily, Usman Sarwar, Joseph Crocetti
Format:	Article
Language:	English
Published:	Greater Baltimore Medical Center 2018-05-01
Subjects:	Methotrexate trimethoprim-sulfamethoxazole deadly drug interaction folinic acid rescue pancytopenia
Online Access:	http://dx.doi.org/10.1080/20009666.2018.1466598